Methadone switching for refractory cancer pain
BMC Palliative Care2022Vol. 21(1), pp. 191–191
Citations Over TimeTop 10% of 2022 papers
Haiying Ding, Yu Song, Wenxiu Xin, Jiao Sun, Like Zhong, Qinfei Zhou, Chaoneng He, Liyan Gong, Fang Luo
Abstract
Methadone is an effective, safe, and cost-saving treatment for patients with refractory cancer pain.
Related Papers
- → Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home.(1998)132 cited
- → Gender‐Specific Differences in Susceptibility to Low‐Dose Methadone‐Associated QTc Prolongation in Patients with Heroin Dependence(2011)31 cited
- → The Use of Low-Dose Methadone as Add-On to Ongoing Opioid Treatment in Palliative Cancer Care—An Underrated Treatment?(2022)14 cited
- → Breaking the barrier: Challenges of methadone use – An introductory observation(2020)2 cited
- → The use of methadone in adult patients with cancer pain at a governmental cancer center in India(2021)2 cited